{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:30:54Z","timestamp":1762432254215,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603609"],"award-info":[{"award-number":["81603609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The relationship between serum uric acid (SUA) levels and paroxysmal atrial fibrillation (AF) remains controversial. The objective of this case\u2013control study was to investigate the association between serum SUA levels and paroxysmal AF by gender in 328 patients. This study included 328 hospitalized patients with newly diagnosed paroxysmal AF in China between January 2019 and September 2021. Controls with sinus rhythm were matched (2:1) to cases by age and gender. Baseline data were analyzed using ANOVA, T-test, and Chi-square test. Pearson correlation analyses were used to confirm the correlation between variables, and multivariate regression analyses were used to adjust for covariates. Elevated SUA levels in female patients were significantly associated with paroxysmal AF after adjusting for confounding factors (OR\u2009=\u20091.229, 95% CI 1.058\u20131.427, <jats:italic>P<\/jats:italic>\u2009=\u20090.007). Further results showed SUA levels were negatively correlated with high-density lipoprotein cholesterol (HDL-C) (r\u2009=\u2009\u2212\u20090.182, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and apolipoprotein A1 (APOA1) (r\u2009=\u2009\u2212\u20090.109, <jats:italic>p<\/jats:italic>\u2009=\u20090.049), were positively correlated with low-density lipoprotein cholesterol (LDL-C) (r\u2009=\u20090.169, <jats:italic>p<\/jats:italic>\u2009=\u20090.002) and prealbumin (PAB) (r\u2009=\u20090.161, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) . Nevertheless, there was no significant complication difference between SUA levels and paroxysmal AF (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). Increased SUA in female patients was significantly associated with paroxysmal AF in a Chinese population. This finding implies that it would be interesting to monitor and interfere with hyperuricemia in paroxysmal AF patients.<\/jats:p>","DOI":"10.1038\/s41598-022-14622-y","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T17:02:57Z","timestamp":1655744577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A case\u2013control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation"],"prefix":"10.1038","volume":"12","author":[{"given":"Xia","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huachen","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"14622_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1161\/CIRCRESAHA.120.316756","volume":"127","author":"V Waldmann","year":"2020","unstructured":"Waldmann, V. et al. Association between atrial fibrillation and sudden cardiac death: Pathophysiological and epidemiological insights. Circ. Res. 127, 301\u2013309. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316756 (2020).","journal-title":"Circ. Res."},{"key":"14622_CR2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1136\/heartjnl-2018-314267","volume":"105","author":"RS Wijesurendra","year":"2019","unstructured":"Wijesurendra, R. S. & Casadei, B. Mechanisms of atrial fibrillation. Heart 105, 1860\u20131867. https:\/\/doi.org\/10.1136\/heartjnl-2018-314267 (2019).","journal-title":"Heart"},{"key":"14622_CR3","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"BP Krijthe","year":"2013","unstructured":"Krijthe, B. P. et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 34, 2746\u20132751. https:\/\/doi.org\/10.1093\/eurheartj\/eht280 (2013).","journal-title":"Eur. Heart J."},{"key":"14622_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/WCO.0000000000000780","volume":"33","author":"JS Healey","year":"2020","unstructured":"Healey, J. S., Amit, G. & Field, T. S. Atrial fibrillation and stroke: How much atrial fibrillation is enough to cause a stroke?. Curr. Opin. Neurol. 33, 17\u201323. https:\/\/doi.org\/10.1097\/WCO.0000000000000780 (2020).","journal-title":"Curr. Opin. Neurol."},{"key":"14622_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jacc.2018.10.077","volume":"73","author":"HC Diener","year":"2019","unstructured":"Diener, H. C., Hart, R. G., Koudstaal, P. J., Lane, D. A. & Lip, G. Y. H. Atrial fibrillation and cognitive function: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 612\u2013619. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.077 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14622_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1161\/CIRCULATIONAHA.118.038312","volume":"139","author":"DD Berg","year":"2019","unstructured":"Berg, D. D. et al. Performance of the ABC scores for assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48. Circulation 139, 760\u2013771. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038312 (2019).","journal-title":"Circulation"},{"key":"14622_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","volume":"133","author":"R Santhanakrishnan","year":"2016","unstructured":"Santhanakrishnan, R. et al. Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction. Circulation 133, 484\u2013492. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018614 (2016).","journal-title":"Circulation"},{"key":"14622_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","volume":"71","author":"RD Lopes","year":"2018","unstructured":"Lopes, R. D. et al. Digoxin and mortality in patients with atrial fibrillation. J. Am. Coll. Cardiol. 71, 1063\u20131074. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.060 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14622_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","volume":"136","author":"DH Lau","year":"2017","unstructured":"Lau, D. H., Nattel, S., Kalman, J. M. & Sanders, P. Modifiable risk factors and atrial fibrillation. Circulation 136, 583\u2013596. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023163 (2017).","journal-title":"Circulation"},{"key":"14622_CR10","doi-asserted-by":"publisher","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","volume":"2","author":"AN Ganesan","year":"2013","unstructured":"Ganesan, A. N. et al. Long-term outcomes of catheter ablation of atrial fibrillation: A systematic review and meta-analysis. J. Am. Heart Assoc. 2, e004549. https:\/\/doi.org\/10.1161\/JAHA.112.004549 (2013).","journal-title":"J. Am. Heart Assoc."},{"key":"14622_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.116.021727","volume":"134","author":"MS Link","year":"2016","unstructured":"Link, M. S., Ha\u00efssaguerre, M. & Natale, A. Ablation of atrial fibrillation: Patient selection, periprocedural anticoagulation, techniques, and preventive measures after ablation. Circulation 134, 339\u2013352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021727 (2016).","journal-title":"Circulation"},{"key":"14622_CR12","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.amjcard.2011.06.043","volume":"108","author":"L Tamariz","year":"2011","unstructured":"Tamariz, L. et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study). Am. J. Cardiol. 108, 1272\u20131276. https:\/\/doi.org\/10.1016\/j.amjcard.2011.06.043 (2011).","journal-title":"Am. J. Cardiol."},{"key":"14622_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","volume":"11","author":"L Tamariz","year":"2014","unstructured":"Tamariz, L., Hernandez, F., Bush, A., Palacio, A. & Hare, J. M. Association between serum uric acid and atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm. 11, 1102\u20131108. https:\/\/doi.org\/10.1016\/j.hrthm.2014.04.003 (2014).","journal-title":"Heart Rhythm."},{"key":"14622_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijcard.2016.11.268","volume":"231","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara, M. et al. Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int. J. Cardiol. 231, 137\u2013142. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.268 (2017).","journal-title":"Int. J. Cardiol."},{"key":"14622_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/jcm10091829","volume":"10","author":"M We\u0142nicki","year":"2021","unstructured":"We\u0142nicki, M. et al. Hyperuricemia as a marker of reduced left ventricular ejection fraction in patients with atrial fibrillation: Results of the POL-AF registry study. J. Clin. Med. 10, 1829. https:\/\/doi.org\/10.3390\/jcm10091829 (2021).","journal-title":"J. Clin. Med."},{"key":"14622_CR16","doi-asserted-by":"publisher","first-page":"594788","DOI":"10.3389\/fcvm.2020.594788","volume":"7","author":"TH Hidru","year":"2020","unstructured":"Hidru, T. H. et al. Does serum uric acid status influence the association between left atrium diameter and atrial fibrillation in hypertension patients?. Front. Cardiovasc. Med. 7, 594788. https:\/\/doi.org\/10.3389\/fcvm.2020.594788 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"14622_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2017.11.083","volume":"252","author":"SG Wannamethee","year":"2018","unstructured":"Wannamethee, S. G., Papacosta, O., Lennon, L. & Whincup, P. H. Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study. Int. J. Cardiol. 252, 187\u2013192. https:\/\/doi.org\/10.1016\/j.ijcard.2017.11.083 (2018).","journal-title":"Int. J. Cardiol."},{"key":"14622_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.amjcard.2013.04.012","volume":"112","author":"F Valbusa","year":"2013","unstructured":"Valbusa, F. et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am. J. Cardiol. 112, 499\u2013504. https:\/\/doi.org\/10.1016\/j.amjcard.2013.04.012 (2013).","journal-title":"Am. J. Cardiol."},{"key":"14622_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/europace\/eux274","volume":"20","author":"H Calkins","year":"2018","unstructured":"Calkins, H. et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 20, e1\u2013e160. https:\/\/doi.org\/10.1093\/europace\/eux274 (2018).","journal-title":"Europace"},{"key":"14622_CR20","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1253\/circj.CJ-18-0748","volume":"82","author":"CH Kwon","year":"2018","unstructured":"Kwon, C. H., Lee, S. H., Lee, J. Y., Ryu, S. & Sung, K. C. Uric acid and risk of atrial fibrillation in the Korean general population. Circ. J. 82, 2728\u20132735. https:\/\/doi.org\/10.1253\/circj.CJ-18-0748 (2018).","journal-title":"Circ. J."},{"key":"14622_CR21","doi-asserted-by":"publisher","first-page":"e019037","DOI":"10.1136\/bmjopen-2017-019037","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Association between serum uric acid and atrial fibrillation: A cross-sectional community-based study in China. BMJ Open 7, e019037. https:\/\/doi.org\/10.1136\/bmjopen-2017-019037 (2017).","journal-title":"BMJ Open"},{"key":"14622_CR22","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.numecd.2021.05.034","volume":"31","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Relationship between serum uric acid levels and different types of atrial fibrillation: An updated meta-analysis. Nutr. Metab. Cardiovasc. Dis. 31, 2756\u20132765. https:\/\/doi.org\/10.1016\/j.numecd.2021.05.034 (2021).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"14622_CR23","first-page":"860","volume":"126","author":"XN He","year":"2013","unstructured":"He, X. N. et al. Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation. Chin. Med. J. (Engl.) 126, 860\u2013864 (2013).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"14622_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.molmed.2011.05.007","volume":"17","author":"K Friedrichs","year":"2011","unstructured":"Friedrichs, K., Klinke, A. & Baldus, S. Inflammatory pathways underlying atrial fibrillation. Trends Mol. Med. 17, 556\u2013563. https:\/\/doi.org\/10.1016\/j.molmed.2011.05.007 (2011).","journal-title":"Trends Mol. Med."},{"key":"14622_CR25","doi-asserted-by":"publisher","first-page":"6859757","DOI":"10.1155\/2019\/6859757","volume":"2019","author":"SS Wu","year":"2019","unstructured":"Wu, S. S. et al. Relationships between serum uric acid, malondialdehyde levels, and carotid intima-media thickness in the patients with metabolic syndrome. Oxid. Med. Cell. Longev. 2019, 6859757. https:\/\/doi.org\/10.1155\/2019\/6859757 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"14622_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","volume":"71","author":"A Srivastava","year":"2018","unstructured":"Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T. & Waikar, S. S. Uric acid and the risks of kidney failure and death in individuals with CKD. Am. J. Kidney Dis. 71, 362\u2013370. https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.017 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"14622_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","volume":"115","author":"P Korantzopoulos","year":"2007","unstructured":"Korantzopoulos, P. et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 115, 135\u2013143. https:\/\/doi.org\/10.1016\/j.ijcard.2006.04.026 (2007).","journal-title":"Int J Cardiol."},{"key":"14622_CR28","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.105.538108","volume":"112","author":"SC Dudley","year":"2005","unstructured":"Dudley, S. C. et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases. Circulation 112, 1266\u20131273. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.538108 (2005).","journal-title":"Circulation"},{"key":"14622_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1185\/03007995.2015.1087980","volume":"31","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz, F. & Becker, M. A. Inflammation: A possible mechanism for a causative role of hyperuricemia\/gout in cardiovascular disease. Curr. Med. Res. Opin. 31, 9\u201314. https:\/\/doi.org\/10.1185\/03007995.2015.1087980 (2015).","journal-title":"Curr. Med. Res. Opin."},{"key":"14622_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/03007995.2017.1378521","volume":"33","author":"AJ Manolis","year":"2017","unstructured":"Manolis, A. J. Serum uric acid and atrial fibrillation. Curr. Med. Res. Opin. 33, 21\u201325. https:\/\/doi.org\/10.1080\/03007995.2017.1378521 (2017).","journal-title":"Curr. Med. Res. Opin."},{"key":"14622_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.hrthm.2012.01.009","volume":"9","author":"KE Odening","year":"2012","unstructured":"Odening, K. E. et al. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm. 9, 823\u2013832. https:\/\/doi.org\/10.1016\/j.hrthm.2012.01.009 (2012).","journal-title":"Heart Rhythm."},{"key":"14622_CR32","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1113\/jphysiol.2010.203398","volume":"589","author":"G Chen","year":"2011","unstructured":"Chen, G. et al. Regional genomic regulation of cardiac sodium-calcium exchanger by oestrogen. J. Physiol. (Lond.) 589, 1061\u20131080. https:\/\/doi.org\/10.1113\/jphysiol.2010.203398 (2011).","journal-title":"J. Physiol. (Lond.)"},{"key":"14622_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.yjmcc.2013.12.014","volume":"67","author":"B Liang","year":"2014","unstructured":"Liang, B. et al. Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis. J. Mol. Cell. Cardiol. 67, 69\u201376. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.12.014 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"14622_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1253\/circj.cj-11-1111","volume":"76","author":"S Suzuki","year":"2012","unstructured":"Suzuki, S. et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ. J. 76, 607\u2013611. https:\/\/doi.org\/10.1253\/circj.cj-11-1111 (2012).","journal-title":"Circ. J."},{"key":"14622_CR35","doi-asserted-by":"publisher","first-page":"e028007","DOI":"10.1136\/bmjopen-2018-028007","volume":"9","author":"WD Lin","year":"2019","unstructured":"Lin, W. D. et al. High prevalence of hyperuricaemia and its impact on non-valvular atrial fibrillation: The cross-sectional Guangzhou (China) Heart Study. BMJ Open 9, e028007. https:\/\/doi.org\/10.1136\/bmjopen-2018-028007 (2019).","journal-title":"BMJ Open"},{"key":"14622_CR36","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1253\/circj.CJ-16-0766","volume":"80","author":"S Kawasoe","year":"2016","unstructured":"Kawasoe, S. et al. Uric acid level and prevalence of atrial fibrillation in a Japanese general population of 285,882. Circ. J. 80, 2453\u20132459. https:\/\/doi.org\/10.1253\/circj.CJ-16-0766 (2016).","journal-title":"Circ. J."},{"key":"14622_CR37","doi-asserted-by":"publisher","first-page":"e012020","DOI":"10.1161\/JAHA.119.012020","volume":"8","author":"S Li","year":"2019","unstructured":"Li, S. et al. Cohort study of repeated measurements of serum urate and risk of incident atrial fibrillation. J. Am. Heart Assoc. 8, e012020. https:\/\/doi.org\/10.1161\/JAHA.119.012020 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"14622_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/europace\/eut260","volume":"16","author":"A Nyrnes","year":"2014","unstructured":"Nyrnes, A. et al. Uric acid is associated with future atrial fibrillation: An 11-year follow-up of 6308 men and women\u2014The Tromso Study. Europace 16, 320\u2013326. https:\/\/doi.org\/10.1093\/europace\/eut260 (2014).","journal-title":"Europace"},{"key":"14622_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.34172\/jcvtr.2020.23","volume":"12","author":"T \u00c7\u0131nar","year":"2020","unstructured":"\u00c7\u0131nar, T., Tan\u0131k, V. O. & G\u00fcrkan, K. Comparison of apolipoprotein-A1 levels between paroxysmal atrial fibrillation patients and healthy subjects. J. Cardiovasc. Thorac. Res. 12, 140\u2013144. https:\/\/doi.org\/10.34172\/jcvtr.2020.23 (2020).","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"14622_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00395-019-0735-0","volume":"114","author":"M Trieb","year":"2019","unstructured":"Trieb, M. et al. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number. Basic Res. Cardiol. 114, 27. https:\/\/doi.org\/10.1007\/s00395-019-0735-0 (2019).","journal-title":"Basic Res. Cardiol."},{"key":"14622_CR41","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/CIRCULATIONAHA.113.005837","volume":"128","author":"KC Yang","year":"2013","unstructured":"Yang, K. C. & Dudley, S. C. Jr. Oxidative stress and atrial fifibrillation: Finding a missing piece to the puzzle. Circulation 128, 1724\u20131726. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005837 (2013).","journal-title":"Circulation"},{"key":"14622_CR42","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","volume":"120","author":"RS Velagaleti","year":"2009","unstructured":"Velagaleti, R. S. et al. Relations of lipid concentrations to heart failure incidence: The Framingham Heart Study. Circulation 120, 2345\u20132351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.830984 (2009).","journal-title":"Circulation"},{"key":"14622_CR43","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 38, 2459\u20132472. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144 (2017).","journal-title":"Eur. Heart J."},{"key":"14622_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacl.2019.12.002","volume":"14","author":"B Guan","year":"2020","unstructured":"Guan, B. et al. Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J. Clin. Lipidol. 14, 133-142.e3. https:\/\/doi.org\/10.1016\/j.jacl.2019.12.002 (2020).","journal-title":"J. Clin. Lipidol."},{"key":"14622_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/ggi.12067","volume":"14","author":"H Kawano","year":"2014","unstructured":"Kawano, H. et al. Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure. Geriatr. Gerontol. Int. 14, 109\u2013114. https:\/\/doi.org\/10.1111\/ggi.12067 (2014).","journal-title":"Geriatr. Gerontol. Int."},{"key":"14622_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejim.2017.05.009","volume":"43","author":"J Franco","year":"2017","unstructured":"Franco, J. et al. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure. Eur. J. Intern. Med. 43, 36\u201341. https:\/\/doi.org\/10.1016\/j.ejim.2017.05.009 (2017).","journal-title":"Eur. J. Intern. Med."},{"key":"14622_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s11845-020-02190-x","volume":"189","author":"M Koca","year":"2020","unstructured":"Koca, M. et al. Impact of atrial fibrillation on frailty and functionality in older adults. Ir. J. Med. Sci. 189, 917\u2013924. https:\/\/doi.org\/10.1007\/s11845-020-02190-x (2020).","journal-title":"Ir. J. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14622-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14622-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:49:38Z","timestamp":1669355378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14622-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14622"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14622-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"23 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10380"}}